165 related articles for article (PubMed ID: 38338696)
1. RNA Profile of Cell Bodies and Exosomes Released by Tumorigenic and Non-Tumorigenic Thyroid Cells.
Maggisano V; Capriglione F; Mio C; Bulotta S; Damante G; Russo D; Celano M
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338696
[TBL] [Abstract][Full Text] [Related]
2. Papillary thyroid cancer-derived exosomes contain miRNA-146b and miRNA-222.
Lee JC; Zhao JT; Gundara J; Serpell J; Bach LA; Sidhu S
J Surg Res; 2015 Jun; 196(1):39-48. PubMed ID: 25819770
[TBL] [Abstract][Full Text] [Related]
3. 5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition.
Cazarin JM; Coelho RG; Hecht F; Andrade BM; Carvalho DP
Thyroid; 2016 Jul; 26(7):933-42. PubMed ID: 27121619
[TBL] [Abstract][Full Text] [Related]
4. Identification of tumorigenesis-related mRNAs associated with RNA-binding protein HuR in thyroid cancer cells.
Baldan F; Mio C; Allegri L; Conzatti K; Toffoletto B; Puppin C; Radovic S; Vascotto C; Russo D; Di Loreto C; Damante G
Oncotarget; 2016 Sep; 7(39):63388-63407. PubMed ID: 27542231
[TBL] [Abstract][Full Text] [Related]
5. Exosomes increased angiogenesis in papillary thyroid cancer microenvironment.
Wu F; Li F; Lin X; Xu F; Cui RR; Zhong JY; Zhu T; Shan SK; Liao XB; Yuan LQ; Mo ZH
Endocr Relat Cancer; 2019 May; 26(5):525-538. PubMed ID: 30870812
[TBL] [Abstract][Full Text] [Related]
6. Identification of Exosomal microRNAs and Their Targets in Papillary Thyroid Cancer Cells.
Maggisano V; Capriglione F; Verrienti A; Celano M; Gagliardi A; Bulotta S; Sponziello M; Mio C; Pecce V; Durante C; Damante G; Russo D
Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625697
[TBL] [Abstract][Full Text] [Related]
7. The expression of HDAC9 and P300 in papillary thyroid carcinoma cell line.
Ozisik H; Ozdil B; Suner A; Sipahi M; Erdogan M; Cetinkalp S; Ozgen G; Saygili F; Oktay G; Aktug H
Pathol Res Pract; 2023 Mar; 243():154385. PubMed ID: 36857949
[TBL] [Abstract][Full Text] [Related]
8.
Kim M; Kim SJ; Xu Z; Ha SY; Byeon JH; Kang EJ; Shin SH; Yoo SK; Jee HG; Yoon SG; Yi JW; Bae JM; Yu HW; Chai YJ; Cho SW; Choi JY; Lee KE; Han W
Thyroid; 2020 Apr; 30(4):487-500. PubMed ID: 32122255
[No Abstract] [Full Text] [Related]
9. SNHG9, a Papillary Thyroid Cancer Cell Exosome-Enriched lncRNA, Inhibits Cell Autophagy and Promotes Cell Apoptosis of Normal Thyroid Epithelial Cell Nthy-ori-3 Through YBOX3/P21 Pathway.
Wen D; Liu WL; Lu ZW; Cao YM; Ji QH; Wei WJ
Front Oncol; 2021; 11():647034. PubMed ID: 34017682
[TBL] [Abstract][Full Text] [Related]
10. Thyrocyte-derived exosome-targeted dendritic cells stimulate strong CD4
Cui X; Wang S; Zhao N; Wang S; Wang Z; Huang M; Liu Y; Qin J; Shan Z; Teng W; Li Y
Mol Cell Endocrinol; 2020 Apr; 506():110756. PubMed ID: 32045626
[TBL] [Abstract][Full Text] [Related]
11. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637.
Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X
Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928
[TBL] [Abstract][Full Text] [Related]
12. ret/PTC-1 expression alters the immunoprofile of thyroid follicular cells.
Denning K; Smyth P; Cahill S; Li J; Flavin R; Aherne S; O' Leary JJ; Sheils O
Mol Cancer; 2008 May; 7():44. PubMed ID: 18505566
[TBL] [Abstract][Full Text] [Related]
13. The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptake.
Tuncel M; Aydin D; Yaman E; Tazebay UH; Güç D; Doğan AL; Taşbasan B; Uğur O
Cancer Biother Radiopharm; 2007 Jun; 22(3):443-9. PubMed ID: 17679169
[TBL] [Abstract][Full Text] [Related]
14. Exosomes Expressing Thyrotropin Receptor Attenuate Autoantibody-Mediated Stimulation of Cyclic Adenosine Monophosphate Production.
Edo N; Kawakami K; Fujita Y; Morita K; Uno K; Tsukamoto K; Onose H; Ishikawa T; Ito M
Thyroid; 2019 Jul; 29(7):1012-1017. PubMed ID: 31062662
[No Abstract] [Full Text] [Related]
15. The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptake.
Tuncel M; Aydin D; Yaman E; Tazebay UH; Güç D; Doğan AL; Taşbasan B; Uğur O
Cancer Biother Radiopharm; 2007 Apr; 22(2):281-8. PubMed ID: 17600477
[TBL] [Abstract][Full Text] [Related]
16. Exosomal ANXA1 derived from thyroid cancer cells is associated with malignant transformation of human thyroid follicular epithelial cells by promoting cell proliferation.
Li Q; Liu W; Wang Z; Wang C; Ai Z
Int J Oncol; 2021 Dec; 59(6):. PubMed ID: 34779491
[TBL] [Abstract][Full Text] [Related]
17. Alternation between toxic and proliferative effects of Roundup® on human thyroid cells at different concentrations.
Dal' Bó IF; Teixeira ES; Rabi LT; Peres KC; Nascimento M; Chiamolera MI; Máximo V; Bufalo NE; Ward LS
Front Endocrinol (Lausanne); 2022; 13():904437. PubMed ID: 35992109
[TBL] [Abstract][Full Text] [Related]
18. DACH1 inhibits the proliferation and migration of papillary thyroid carcinoma.
Liang S; Xu Q; Liu B; Hu R; Lai J; Wang W; Yu X; Gou J; Wang L; Chen Y; Ji Q; Zhou J
Cell Biol Int; 2023 Mar; 47(3):612-621. PubMed ID: 36511182
[TBL] [Abstract][Full Text] [Related]
19. Exosomal miRNAs are potential diagnostic biomarkers between malignant and benign thyroid nodules based on next-generation sequencing.
Pan Q; Zhao J; Li M; Liu X; Xu Y; Li W; Wu S; Su Z
Carcinogenesis; 2020 Mar; 41(1):18-24. PubMed ID: 31560760
[TBL] [Abstract][Full Text] [Related]
20. Hypoxic papillary thyroid carcinoma cells-secreted exosomes deliver miR-221-3p to normoxic tumor cells to elicit a pro-tumoral effect by regulating the ZFAND5.
Yu F; Deng X; Zhong Y; Guo B; Zhang X; Wu B
Exp Cell Res; 2023 Oct; 431(1):113716. PubMed ID: 37488006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
